Wegman Mark N 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 17, 2019
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2019-05-15$20.95/sh+15,000$314,250→ 80,272 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-15−15,000→ 0 totalExercise: $20.95Exp: 2019-06-24→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vested monthly with respect to 1/12 of the total number of shares from the date of grant (6/25/2009).